MDS
Sep 15, 2023
Myelodysplastic Syndrome Treatment Market: Unveiling the Robust Pipeline
The number of people diagnosed with myelodysplastic syndrome in the US each year is unknown. However, some estimates have put this number at about 10,000, while other estimates have been much higher. Moreover, myelodysplastic syndrome is uncommon before age 50, and the risk increases as a person gets older. It is a...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
